Stocks analysis

Analysis for PFE

$29.44 +0.23 (+0.79%)
  • 📈 Growth — 4/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 14/20
  • ⚠️ Risk — 7/10
Overall Score: 55/100

Summary:


📈 Growth & Financial Trajectory

Revenues started at 17.70B in 2024 Q3 and ended at 15.03B in 2026 Q2, a roughly -15% decline. Net Income moved from a solid +4.47B to a small loss of about -0.24B, with a peak in 2025 Q3 (+3.55B) and losses in 2025 Q4 through 2026 Q2. The pattern shows revenue stability but waning earnings power, culminating in a weaker bottom line as of 2026. Overall, the trajectory suggests modest top-line resilience but increasing earnings risk should revenue stay pressured.

💰 Margins & Cash Flow

  • Gross margins remained high, roughly in the 70%–80% range across eight quarters (e.g., 70.3% in 2024 Q3/Q4; ~79% in 2025 Q1; ~72–75% thereafter), indicating strong product profitability.
  • Operating income was positive in most periods but swung negative in 2025 Q4 and 2026 Q2, signaling evolving cost dynamics and operating leverage shifts.
  • Cash flow: operating cash flow was generally positive, while investing activities were cash outflows (typical capex/investing), yielding mixed to modestly negative overall cash flow in some quarters.

🛡️ Balance Sheet & Liquidity

Total assets run ~206–208B with liabilities ~115–126B and equity ~85–90B, producing a solid balance of assets vs liabilities. Current assets and current liabilities are roughly aligned in the latest periods, producing a near-1.0 current ratio. The balance sheet shows substantial liquidity headroom and a durable equity base, supporting resilience through earnings volatility.

⚠️ Key Drivers & Risks

  • Drivers: Strong gross margins across quarters; robust cash flow generation.
  • Risks: Earnings volatility due to quarterly mix and recent losses; sensitivity to product pipeline and regulatory/patent dynamics.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $157.03B
P/E Ratio 36.24
Forward P/E 8.64
P/S Ratio 2.47
P/B Ratio 1.63
EV / EBITDA 23.97
Profitability & Returns
Gross Margin 74.71%
Operating Margin 6.79%
Net Margin 6.80%
ROE 4.89%
ROIC 2.85%
Financial Health & Liquidity
Current Ratio 1.27
Quick Ratio 0.96
Financial Scale & Cash Flow
Revenue $63.69B
Net Income $4.33B
FCF Yield 7.00%
Free Cash Flow $10.99B
Total Debt To Equity 0.74